Haploidentical Stem Cell Transplantation With TCR αβ+/CD19+ Depletion in Children With Nonmalignant Hematologic Disorders: Outcomes From a Referral Center in Peru
Transplantation Proceedings · 2024
DOI: 10.1016/j.transproceed.2024.08.038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Jackeline Carol Rodríguez-Torres und 3 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Trasplante de Progenitores Hematopoyéticos, Instituto Nacional de Salud del Niño San Borja, Lima 15037, Perú. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Antigens, CD19, Hematologic Diseases, Transplantation, Haploidentical. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with TCR αβ+/CD19+ cell depletion is a promising therapeutic alternative for children with nonmalignant hematologic disorders, especially in low-income countries where finding a compatible donor is challenging. The use of this transplantation approach for nonmalignant hematologic disorders has not been previously described in the Peruvian pediatric population. METHODS: We present the outcomes of children under 19 with nonmalignant hematologic disorders who underwent haplo-HSCT with TCR αβ+/CD19+ cell depletion between 2018-2022 at a referral center in Lima, Peru. Survival probabilities and cumulative incidence functions were calculated using the Kaplan-Meier method. RESULTS: A total of 17 children aged between 1 to 18.6 years (median = 9.7 years) were included. The follow-up period ranged from 10 days to 66.20 months, with a median of 4.34 months. The probability of overall survival, event-free survival, and failure-free survival was 33.70%, 31.40%, and 68.8%, respectively. The incidence rate of graft failure was 49.80%, while the mortality rate not associated with graft failure was 18.8%. The incidence rate of acute graft-versus-host disease (GvHD) was 25.60%, and the incidence rate of viral infections was 59.40%. CONCLUSIONS: The high incidence rates of graft failure and viral infections suggest that these factors may negatively impact the survival of children with nonmalignant hematologic disorders who undergo haplo-HSCT with TCR αβ+/CD19+ cell depletion. Therefore, optimizing the current conditioning regimens and ensuring timely access to first, second, and third-line antivirals is crucial to improve the survival of these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Servicio de Trasplante de Progenitores Hematopoyéticos, Instituto Nacional de Salud del Niño San Borja, Lima 15037, Perú.
- Laboratorios de Investigación y Desarrollo. Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia, Lima 15102, Perú. Electronic address: alejandra.pando@upch.pe.
- Sub Unidad de Investigación e Innovación Tecnológica, Instituto Nacional de Salud del Niño San Borja, Lima 15037, Perú.
- Unidad de Trasplante de Médula Ósea, Hospital Nacional Edgardo Rebagliati Martins, Lima 15072, Perú.
Zitieren
APA
Rodríguez-Torres, J. C., Pando-Caciano, A., Mamaní-Cajachagua, P. E., & Murillo-Vizcarra, S. A. (2024). Haploidentical Stem Cell Transplantation With TCR αβ+/CD19+ Depletion in Children With Nonmalignant Hematologic Disorders: Outcomes From a Referral Center in Peru. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.08.038
Vancouver
Rodríguez-Torres JC, Pando-Caciano A, Mamaní-Cajachagua PE, Murillo-Vizcarra SA. Haploidentical Stem Cell Transplantation With TCR αβ+/CD19+ Depletion in Children With Nonmalignant Hematologic Disorders: Outcomes From a Referral Center in Peru. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.08.038
BibTeX
@article{RodrguezTorres2024,
author = {Rodríguez-Torres, Jackeline Carol and Pando-Caciano, Alejandra and Mamaní-Cajachagua, Pauline E and Murillo-Vizcarra, Sergio A},
title = {Haploidentical Stem Cell Transplantation With TCR αβ+/CD19+ Depletion in Children With Nonmalignant Hematologic Disorders: Outcomes From a Referral Center in Peru},
journal = {Transplantation Proceedings},
year = {2024},
doi = {10.1016/j.transproceed.2024.08.038}
}
EUVIMED